The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population

被引：2

作者：

Ng, Wai-Yoong ^{[1
]}

Lim, Daniel Yan-Zheng ^{[2
,3
]}

Tan, Si-Yu ^{[1
]}

Chang, Jason Pik-Eu ^{[4
]}

Krishnamoorthy, Thinesh Lee ^{[4
]}

Lim, Chee-Hooi ^{[4
]}

Tan, Damien Meng-Yew ^{[4
]}

Ekstrom, Victoria Sze-Min ^{[4
]}

Goh, George Boon-Bee ^{[4
]}

Cheah, Mark Chang-Chuen ^{[4
]}

Kumar, Rajneesh ^{[4
]}

Yeo, Chin-Pin ^{[1
]}

Tan, Chee-Kiat ^{[4
,5
]}

机构：

[1] Singapore Gen Hosp, Dept Clin Pathol, Singapore, Singapore

[2] Singapore Gen Hosp, Med Board, Hlth Serv Res Unit, Singapore, Singapore

[3] Duke NUS Med Sch, Med Acad Clin Programme, Singapore, Singapore

[4] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore, Singapore

[5] Academia, Dept Gastroenterol & Hepatol, Level 3,20 Coll Rd, Singapore 169856, Singapore

来源：

ANNALS ACADEMY OF MEDICINE SINGAPORE | 2023年 / 52卷 / 02期

关键词：

DES-GAMMA-CARBOXYPROTHROMBIN; ALPHA-FETOPROTEIN;

D O I：

10.47102/annals-acadmedsg.2022351

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：108 / 110

页数：3

共 50 条

[31] PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
Feng, Honglei
Li, Bole
Li, Ze
Wei, Qian
Ren, Li
BMC CANCER, 2021, 21 (01)
[32] Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma
Tanaka, Y
Kashiwagi, T
Tsutsumi, H
Nagasawa, M
Toyama, T
Ozaki, S
Naito, M
Ishibashi, K
Azuma, M
HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2464 - 2468
[33] Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Pote, Nicolas
Cauchy, Franois
Albuquerque, Miguel
Voitot, Helene
Belghiti, Jacques
Castera, Laurent
Puy, Herve
Bedossa, Pierre
Paradis, Valerie
JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 848 - 854
[34] PIVKA-II for prediction of microvascular invasion in hepatocellular carcinomas
Pote, N.
Cauchy, F.
Albuquerque, M.
Voitot, H.
Belghiti, J.
Castera, L.
Puy, H.
Bedossa, P.
Paradis, V.
VIRCHOWS ARCHIV, 2014, 465 : S308 - S308
[35] Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
Yu, Rentao
Ding, Shitao
Tan, Wenting
Tan, Shun
Tan, Zhaoxia
Xiang, Shiqing
Zhou, Yi
Mao, Qing
Deng, Guohong
HEPATITIS MONTHLY, 2015, 15 (07)
[36] Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma
Jin, Yujiao
Xu, Aifang
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024,
[37] Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma
Park, M. -S.
Lee, K. -W.
Kim, H.
Choi, Y. R.
Hong, G.
Yi, N. -J.
Suh, K. -S.
TRANSPLANTATION PROCEEDINGS, 2017, 49 (05) : 1109 - 1113
[38] PIVKA-II and biochemical parameters in patients with hepatocellular carcinoma on waiting list for liver transplantation
Alconchel, F.
Villalba-Lopez, F.
Saez, L.
Sanchez-Lorencio, I.
Medievo, B.
Ferreras, D.
Cascales-Campos, P. A.
Martinez-Alarcon, L.
Febrero, B.
Nicolas-Lopez, T.
Rios, A.
Martinez-Insfran, L. A.
Robles, R.
Sanchez-Bueno, F.
Parrilla, P.
Ramirez, P.
TRANSPLANTATION, 2021, 105 (08) : 80 - 80
[39] Investigating a Prognostic Factor for Canine Hepatocellular Carcinoma: Analysis of Different Histological Grading Systems and the Role of PIVKA-II
Maniscalco, Lorella
Varello, Katia
Morello, Emanuela
Montemurro, Vittoria
Olimpo, Matteo
Giacobino, Davide
Abbamonte, Giuseppina
Gola, Cecilia
Iussich, Selina
Bozzetta, Elena
VETERINARY SCIENCES, 2022, 9 (12)
[40] Performance evaluation of the Elecsys PIVKA-II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
Chan, Henry L. Y.
Vogel, Arndt
Berg, Thomas
De Toni, Enrico N.
Kudo, Masatoshi
Trojan, Joerg
Eiblmaier, Anja
Klein, Hanns-Georg
Hegel, Johannes Kolja
Sharma, Ashish
Madin, Kairat
Rolny, Vinzent
Lisy, Marcus-Rene
Piratvisuth, Teerha
JGH OPEN, 2022, 6 (05): : 292 - 300

← 1 2 3 4 5 →